The previous page is sending you to https://www.medical-tribune.de/medizin-und-forschung/artikel/fortgeschrittenes-ovarialkarzinom-mehr-als-15-monate-bevacizumab-erhaltung-lohnen-sich-nicht.

 If you do not want to visit that page, you can return to the previous page.